Deca
|
Questions
|
VH
|
H
|
M
|
L
|
VL
|
No. Resp.
|
Mean
|
Std
|
CNS
|
RANK (CONS)
|
| |
5
|
4
|
3
|
2
|
1
| | | | | |
|
Environmental Matrix
| | | | | | | | | | |
EM3
|
Sediments
|
2
|
13
|
5
|
3
|
0
|
23
|
3.61
|
0.69
|
0.71
|
25
|
EM4
|
Sewage sludge
|
2
|
12
|
7
|
2
|
0
|
23
|
3.61
|
0.84
|
0.73
|
20
|
EM5
|
Soil
|
3
|
9
|
7
|
4
|
0
|
23
|
3.48
|
0.78
|
0.66
|
39
|
|
Level of exposure
| | | | | | | | | | |
EX2
|
Occupationally exposed
|
1
|
12
|
8
|
2
|
0
|
23
|
3.52
|
0.73
|
0.75
|
15
|
|
Main sources of exposure
| | | | | | | | | | |
EX5
|
Occupationally exposed
|
3
|
13
|
6
|
1
|
0
|
23
|
3.78
|
0.74
|
0.77
|
12
|
|
Occupational exposed
| | | | | | | | | | |
EX11
|
Inhalation
|
4
|
8
|
10
|
1
|
0
|
23
|
3.65
|
0.83
|
0.71
|
27
|
|
Infants and children
| | | | | | | | | | |
EX17
|
Via breast milk
|
2
|
14
|
4
|
2
|
1
|
23
|
3.61
|
0.94
|
0.68
|
34
|
|
Toxicokinetics
| | | | | | | | | | |
TK10
|
Final metabolite concentration in target tissues
|
0
|
1
|
3
|
10
|
9
|
23
|
1.83
|
0.83
|
0.73
|
22
|
|
Human Epidemiological studies
| | | | | | | | | | |
TX01
|
Males
|
0
|
1
|
5
|
7
|
9
|
22
|
1.91
|
0.92
|
0.68
|
33
|
TX02
|
Females
|
0
|
1
|
4
|
7
|
10
|
22
|
1.82
|
0.91
|
0.69
|
32
|
|
Knowledge of the mechanisms of actions
| | | | | | | | | | |
TX16
|
Metabolites of BDE209
|
0
|
2
|
1
|
14
|
5
|
22
|
2.00
|
0.82
|
0.80
|
4
|
(b)
|
Deca
|
Questions
|
VH
|
H
|
M
|
L
|
VL
|
No.Resp.
|
Mean
|
Std
|
CNS
|
RANK (CONS)
|
| |
5
|
4
|
3
|
2
|
1
| | | | | |
|
Environmental Matrix
| | | | | | | | | | |
EM6
|
Water
|
2
|
4
|
8
|
6
|
3
|
23
|
2.83
|
0.95
|
0.59
|
57
|
|
Level of exposure
| | | | | | | | | | |
EX1
|
The general population
|
0
|
2
|
15
|
6
|
0
|
23
|
2.83
|
0.58
|
0.83
|
2
|
|
General population
| | | | | | | | | | |
EX9
|
Ingestion
|
1
|
4
|
14
|
4
|
0
|
23
|
3.09
|
0.73
|
0.80
|
5
|
|
Occupational exposed
| | | | | | | | | | |
EX10
|
Direct contact dermal
|
0
|
3
|
15
|
5
|
0
|
23
|
2.91
|
0.60
|
0.84
|
1
|
|
Toxicokinetics
| | | | | | | | | | |
TK04
|
Debrominated or metabolized by the intestinal microflora
|
0
|
0
|
7
|
15
|
1
|
23
|
2.26
|
0.54
|
0.82
|
3
|
TK07
|
Excreted via urine
|
2
|
5
|
5
|
8
|
3
|
23
|
2.78
|
1.20
|
0.55
|
58
|
|
Neurodevelopment
| | | | | | | | | | |
TX05
|
Males exposed during fetal or neonatal life
|
2
|
2
|
8
|
7
|
3
|
22
|
2.68
|
1.13
|
0.60
|
55
|
TX06
|
Females exposed during fetal or neonatal life
|
2
|
1
|
9
|
6
|
4
|
22
|
2.59
|
1.14
|
0.59
|
56
|
|
Reproductive function in
| | | | | | | | | | |
TX13
|
Males exposed during foetal or neonatal life
|
1
|
3
|
7
|
7
|
4
|
22
|
2.55
|
1.10
|
0.60
|
53
|
TX14
|
Females exposed during foetal or neonatal life
|
1
|
3
|
7
|
7
|
4
|
22
|
2.55
|
1.10
|
0.60
|
54
|
|
Knowledge of the mechanisms of actions
| | | | | | | | | | |
TX16
|
Metabolites of BDE209
|
0
|
2
|
1
|
14
|
5
|
22
|
2.00
|
0.82
|
0.80
|
4
|